» Articles » PMID: 31322241

Functional Analysis of the Congenital Heart Disease‑associated GATA4 H436Y Mutation In vitro

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2019 Jul 20
PMID 31322241
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital heart disease (CHD) is the most common type of developmental defect, with high rates of morbidity in infants. The transcription factor GATA‑binding factor 4 (GATA4) has been reported to serve a critical role in embryogenesis and cardiac development. Our previous study reported a heterozygous GATA4 c.1306C>T (p.H436Y) mutation in four Chinese infants with congenital heart defects. In the present study, functional analysis of the GATA4 H436Y mutation was performed in vitro. The functional effect of GATA4 mutation was compared with GATA4 wild‑type using a dual‑luciferase reporter assay system and immunofluorescence. Electrophoretic mobility‑shift assays were performed to explore the binding affinity of the mutated GATA4 to the heart and neural crest derivatives expressed 2 (HAND2) gene. The results revealed that the mutation had no effect on normal nuclear localization, but resulted in diminished GATA‑binding affinity to HAND2 and significantly decreased gene transcriptional activation. These results indicated that this GATA4 mutation may not influence cellular localization in transfected cells, but may affect the affinity of the GATA‑binding site on HAND2 and decrease transcriptional activity, thus suggesting that the GATA4 mutation may be associated with the pathogenesis of CHD.

Citing Articles

Targeting senescence and GATA4 in age-related cardiovascular disease: a comprehensive approach.

Imran M, Altamimi A, Afzal M, Babu M, Goyal K, Ballal S Biogerontology. 2025; 26(1):45.

PMID: 39831933 DOI: 10.1007/s10522-025-10189-z.


analysis of variants demonstrates main contribution to congenital heart disease.

Abbasi S, Mohsen-Pour N, Naderi N, Rahimi S, Maleki M, Kalayinia S J Cardiovasc Thorac Res. 2022; 13(4):336-354.

PMID: 35047139 PMC: 8749364. DOI: 10.34172/jcvtr.2021.45.


Transcriptional Regulation of Postnatal Cardiomyocyte Maturation and Regeneration.

Padula S, Velayutham N, Yutzey K Int J Mol Sci. 2021; 22(6).

PMID: 33807107 PMC: 8004589. DOI: 10.3390/ijms22063288.

References
1.
Srivastava D, Olson E . A genetic blueprint for cardiac development. Nature. 2000; 407(6801):221-6. DOI: 10.1038/35025190. View

2.
McFADDEN D, Charite J, Richardson J, Srivastava D, Firulli A, Olson E . A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. Development. 2000; 127(24):5331-41. DOI: 10.1242/dev.127.24.5331. View

3.
Dai Y, Cserjesi P, Markham B, Molkentin J . The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism. J Biol Chem. 2002; 277(27):24390-8. DOI: 10.1074/jbc.M202490200. View

4.
Kaetzke A, Eschrich K . Simultaneous determination of different DNA sequences by mass spectrometric evaluation of Sanger sequencing reactions. Nucleic Acids Res. 2002; 30(21):e117. PMC: 135840. DOI: 10.1093/nar/gnf116. View

5.
Garg V, Kathiriya I, Barnes R, Schluterman M, King I, Butler C . GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003; 424(6947):443-7. DOI: 10.1038/nature01827. View